1983
DOI: 10.1042/bj2110671
|View full text |Cite
|
Sign up to set email alerts
|

Rapid preparation of human insulin and insulin analogues in high yield by enzyme-assisted semi-synthesis

Abstract: Reaction conditions are described that permit the enzyme-assisted semi-synthetic replacement of residue B30 of pig insulin (or of analogue) to proceed in very high yield in 2 h or less. Immobilized trypsin may be used as catalyst, and excess amino acid ester may be recycled after a simple extraction. Alanine-B30 may be replaced by a variety of nucleophiles, including threonine O-t-butyl ether t-butyl ester, in which case the yield of crude product is about 99%. De-protection of the B30 threonyl ester analogue … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
18
0

Year Published

1984
1984
2018
2018

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 24 publications
(18 citation statements)
references
References 6 publications
0
18
0
Order By: Relevance
“…The insulin precursor was converted enzymatically into insulin ester via transpeptidation [1820] in the presence of trypsin and an excess of O-t-butyl-L-threonine t-butyl ester (H-Thr(tBu)-OtBu) acetate salt. Trypsin mediates cleavage of the N-terminal spacer peptide and the Ala-Ala-Lys connecting linker peptide and the transesterification reaction where threonine ester is added to B-29 residue as previously described [6].…”
Section: Resultsmentioning
confidence: 99%
“…The insulin precursor was converted enzymatically into insulin ester via transpeptidation [1820] in the presence of trypsin and an excess of O-t-butyl-L-threonine t-butyl ester (H-Thr(tBu)-OtBu) acetate salt. Trypsin mediates cleavage of the N-terminal spacer peptide and the Ala-Ala-Lys connecting linker peptide and the transesterification reaction where threonine ester is added to B-29 residue as previously described [6].…”
Section: Resultsmentioning
confidence: 99%
“…Arg-38 is specifically removed from (1-38) by carboxypeptidase B (Harris, 1978); (39-104) is trun-,ated by a single Edman degradation cycle by the method of Wallace & Corthesy (1986) for (66-104), but with the use of diethyl ether precipitation, instead of ethyl acetate extraction, to free the peptide of small molecule contaminants. Elongation of (1-38) is performed by reverse proteolysis with trypsin: -the equilibrium is shifted by high concentrations of organic solvent and the nucleophile, an amino acid ester (Rose et al, 1983). Stepwise elongation at the N-terminus of (38-104) or (39-104) requires amino acid active esters; for residues other than arginine, we employed N-hydroxysuccinimide esters (Wallace & Corthesy, 1986).…”
Section: Discussionmentioning
confidence: 99%
“…Octadeutero-PheBl-octadeutero-ValB2 human insulin (DHI) and octadeutero-PheBl-octadeutero-ValB2 porcine insulin (DPI) were prepared as described by Stocklin et al (37). Des-AlaB30 porcine insulin (DAI) was obtained by enzymatic cleavage with Achromobacter lyticus protease of DAI-Thr(Bu l )-O-Bu', prepared essentially as previously described (42). The preparation of recombinant human insulin uniformly labeled with 99.4% 15 N (NHI) will be described elsewhere (R.S., J.-F. Arrighi, K. Hoang-Van, F.C., R.E.O., K.R., unpublished observations).…”
Section: Methodsmentioning
confidence: 99%